日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3

19,20-环氧二十二碳五烯酸 (19,20-EDP) 在缺血性损伤中的心脏保护作用涉及线粒体 sirtuin 3 的直接激活

Darwesh, Ahmed M; Fang, Liye; Altamimi, Tariq R; Jamieson, K Lockhart; Bassiouni, Wesam; Valencia, Robert; Huang, Andy; Wang, Faqi; Zhang, Hao; Ahmed, Marawan; Gopal, Keshav; Zhang, Yongneng; Michelakis, Evangelos D; Ussher, John R; Edin, Matthew L; Zeldin, Darryl C; Barakat, Khaled; Oudit, Gavin Y; Kassiri, Zamaneh; Lopaschuk, Gary D; Seubert, John M

Casein Kinase 2α Ablation Confers Protection Against Metabolic Dysfunction-Associated Steatotic Liver Disease: Role of FUN14 Domain Containing 1-Dependent Regulation of Mitophagy and Ferroptosis.

酪蛋白激酶 2α 消融可预防代谢功能障碍相关的脂肪肝疾病:FUN14 结构域包含 1 依赖性线粒体自噬和铁死亡调节的作用

He Ke, Zhan Meixiao, Luo Xuanming, Li Ruibing, Lin Ling, Lin Jie, Li Liheng, Chen Hongdong, Lopaschuk Gary D, Zhou Hao, Liu Fei, Ren Jun

Alterations of myocardial ketone metabolism in heart failure with preserved ejection fraction (HFpEF).

射血分数保留型心力衰竭(HFpEF)中心肌酮代谢的改变

Sun Qiuyu, Wagg Cory S, Wong Nathan, Wei Kaleigh, Ketema Ezra B, Zhang Liyan, Fang Liye, Seubert John M, Lopaschuk Gary D

Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?

甜味剂:赤藓糖醇、木糖醇与心血管风险——是朋友还是敌人?

Wölnerhanssen, Bettina K; Meyer-Gerspach, Anne Christin; Arduini, Arduino; D'Alessandro, Angelo; Gronda, Edoardo; Carugo, Stefano; Bonomini, Mario; Gallieni, Maurizio; Masola, Valentina; Angelillo-Scherrer, Anne; Prosdocimi, Tommaso; Lopaschuk, Gary D

Cardiac energy substrate utilization in heart failure with preserved ejection fraction: reconciling conflicting evidence on fatty acid and glucose metabolism

射血分数保留型心力衰竭患者的心脏能量底物利用:脂肪酸和葡萄糖代谢相关矛盾证据的调和

Shehadeh, Lina A; Robleto, Emely; Lopaschuk, Gary D

The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC

心力衰竭中免疫激活与代谢的相互作用。欧洲心脏病学会心力衰竭协会的科学声明

Fragasso, Gabriele; Stolfo, Davide; Anker, Markus S; Bayes-Genis, Antoni; Chioncel, Ovidiu; Heymans, Stephane; Jhund, Pardeep S; Lewis, Basil S; Lopaschuk, Gary D; Lund, Lars H; Gonzalez, Arantxa; Pagnesi, Matteo; Schiattarella, Gabriele Giacomo; Tocchetti, Carlo Gabriele; van der Meer, Peter; Van Linthout, Sophie; Wassmann, Sven; Westenbrink, B Daan; Metra, Marco; Rosano, Giuseppe M C; Savarese, Gianluigi

Anaplerotic filling in heart failure: a review of mechanism and potential therapeutics

心力衰竭中的补充充盈:机制和潜在治疗方法的综述

Alhasan, Karm A; King, Melissa A; Pattar, Badal S B; Lewis, Ian A; Lopaschuk, Gary D; Greenway, Steven C

Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

心肌能量代谢研究进展:心力衰竭及其他疾病中的代谢重塑

Sun, Qiuyu; Karwi, Qutuba G; Wong, Nathan; Lopaschuk, Gary D

Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF).

在射血分数降低的心力衰竭 (HFrEF) 临床前小鼠模型中,脂联素受体激动剂 ALY688 具有心脏保护作用

Cho Sungji, Dadson Keith, Sung Hye Kyoung, Ayansola Oyeronke, Mirzaesmaeili Ali, Noskovicova Nina, Zhao Yimu, Cheung Krisco, Radisic Milica, Hinz Boris, Sater Ali A Abdul, Hsu Henry H, Lopaschuk Gary D, Sweeney Gary

Pharmacological Inhibition of Succinyl Coenzyme A:3-Ketoacid Coenzyme A Transferase Alleviates the Progression of Diabetic Cardiomyopathy

琥珀酰辅酶A:3-酮酸辅酶A转移酶的药理学抑制可缓解糖尿病心肌病的进展

Greenwell, Amanda A; Tabatabaei Dakhili, Seyed Amirhossein; Wagg, Cory S; Saed, Christina T; Chan, Jordan S F; Yang, Kunyan; Mangra-Bala, Indiresh A; Stenlund, Magnus J; Eaton, Farah; Gopal, Keshav; Dyck, Jason R B; Lopaschuk, Gary D; Ussher, John R